Thus, it is not known whether PTCH2-caused BCNS is, for example, a rarely reported subtype with a milder phenotype than BCNS arising from other mutations [11] or PTCH2 does not predispose to BCNS but, instead, is a phenotype modifier [12]. This evidence concerns the gene PTCH2 and nevoid basal cell carcinoma syndrome.